Project Grant R01DC021326

Award Date 6/10/24
Completion Date 5/31/29
Dollars Obligated $726K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94304, USA
Similar Awards
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $713,170 to The Leland Stanford Junior University to develop and validate a Multimodality Micro-Optical Coherence Tomography (MM-MOCT) technology. The MM-MOCT system is designed to obtain high-resolution, cross-sectional images of cellular microstructure and co-localized images of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 provides funding to Ironsides Medical Inc. to develop a novel automated diagnostic medical device technology for diagnosing ear infections, a common condition affecting up to 80% of all U.S. children by age three. The project aims to improve ear infection diagnostics by integrating a high-resolution camera onto an active otoscope and developing advanced machine learning...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Federal Grant Program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), will support research using optical coherence tomography (OCT) to visualize the fluid compartments of the human inner ear. The $701,848 award will be used to characterize the normal endolymph-to-perilymph ratio in control subjects, and compare it to subjects with Meniere's...
This federal Project Grant award of $722,677, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), is aimed at improving the diagnosis and understanding of otitis media with effusion (OME) and its related hearing loss in children. The primary objectives are to: 1) develop a non-invasive objective estimate of hearing loss due to OME, 2) characterize the short-term...
This federal Project Grant award of $460,164 from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) will fund research training to develop future leaders and innovators in the field of otolaryngology. Over a 5-year period from July 2024 to June 2029, the grant will provide tailored mentored research experiences for 2 otolaryngology residents per year as well as 2 medical students...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $277,810 Project Grant under the Research Related to Deafness and Communication Disorders program (CFDA 93.173) to Femtovox Incorporated, a for-profit organization located in Ladera Ranch, CA. The funding supports the development of an image-guided automated ultrafast laser device for laryngeal (voice box) surgery. The device is designed to provide real-time optical coherence tomography (OCT) imaging to...
The National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders Federal Grant Program (CFDA 93.173), awarded a $417,741 project grant to the Massachusetts Institute of Technology (MIT) to develop computational models that replicate human auditory abilities. The goal is to improve prosthetic devices and therapeutic interventions for individuals with hearing impairment, cochlear implants, and auditory...
Pionear Technologies Inc. received a $699,002 Project Grant award from the National Institute on Deafness and Other Communication Disorders within the Department of Health and Human Services. The award is part of the Research Related to Deafness and Communication Disorders federal grant program (CFDA 93.173) to develop novel liquid-infused tympanostomy tubes with optimized lumen geometry and slippery material design. The goal of the project is to engineer tympanostomy tubes that more efficiently...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), will provide $415,743 to Oregon Health & Science University (OHSU) from February 1, 2025 to January 31, 2030. The award will fund research to investigate the role of macrophages (immune cells) in the development, homeostasis, and repair of the tympanic membrane (eardrum). The project...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $674,021 to the Massachusetts Eye and Ear Infirmary to advance the development of an implantable microphone technology for totally-implantable cochlear implants (TICI). The project aims to refine and test a novel implantable microphone design called the UMIC, which senses motion of...

This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA Program 93.173 "Research Related to Deafness and Communication Disorders" is focused on developing innovative diagnostic imaging methods for otitis media, a common childhood condition. The $726,079 award will support research conducted by The Leland Stanford Junior University to create three advanced optical imaging techniques: 1) shortwave infrared fluorescence otoscopy to detect bacterial infections, 2) spatial offset Raman spectroscopy to analyze molecular changes in the tympanic membrane, and 3) shortwave infrared otoscopy to diagnose middle ear effusions. A sub-award to the Massachusetts Institute of Technology will integrate the SWIR imaging and NIR Raman spectroscopy technologies into an otoscope device. This research aims to improve the diagnosis and monitoring of otitis media compared to current methods, which can lead to reduced antibiotic overuse. The award period is from June 10, 2024 to May 31, 2029.

Generated 4/29/25, 4:49 AM